Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging

International Journal of Gynecological Cancer

Volumn 16, Issue 5, 2006, Pages 1846-1854

  Choi, Y S ^a   Yi, C M ^a   Sin, J I ^a   Ye, G W ^a   Shin, I H ^a   Lee, T S ^a  

^a Catholic University of Daegu   (South Korea)

Author keywords

Cervical cancer; Chemoradiation; Hemoglobin; Lymph node metastasis

Indexed keywords

CISPLATIN; DEXAMETHASONE; FLUOROURACIL; HEMOGLOBIN; ONDANSETRON; PACLITAXEL; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIATION INJURY; RETROSPECTIVE STUDY; REVIEW; UNIVARIATE ANALYSIS; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC AGENTS; CARCINOMA; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBINS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT FAILURE; UTERINE CERVICAL NEOPLASMS;

EID: 33749120970     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00666.x     Document Type: Review

References (27)

1. Varlotto J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys 2005;63:25-36.
2. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001;91:2214-21.
3. Grogan M, Thomas GM, Melamed I et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-36.
4. Dunst J, Kuhnt T, Strauss HG et al. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 2003;56:778-87.
5. Dische S. Radiotherapy and anaemia - the clinical experience. Radiother Oncol 1991;20(Suppl. 1):35-40.
6. Obermair A, Cheuk R, Horwood K et al. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Cancer 2001;92:903-8.
7. Obermair A, Cheuk R, Horwood K et al. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: effect on progression-free survival. Int J Gynecol Cancer 2003;13:633-9.
8. Thomas G. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Semin Oncol 2001;28(2 Suppl. 8):60-5.
9. Winter WE III, Maxwell GL, Tian C et al. Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol 2004;94:495-501.
10. Hockel M, Knoop C, Schlenger K et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50.
11. NCI Clinical Announcement. Concurrent chemoradiation for cervical cancer. Bethesda (MD): US Department of Public Health, 1999.
12. Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-48.
13. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
14. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
15. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
16. Peters WA III, Liu PY, Barrett RJ II et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.
17. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995;58:157-8.
18. Girinski T, Pejovic-Lenfant MH, Bourhis J et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989;16:37-42.
19. Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1309-17.
20. Spivak JL. Cancer-related anemia: its causes and characteristics. Semin Oncol 1994;21(2 Suppl. 3):3-8.
21. Mercadante S, Gebbia V, Marrazzo A, Filosto S. Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev 2000;26:303-11.
22. Lavey RS, Liu PY, Greer BE et al. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study. Gynecol Oncol 2004;95:145-51.
23. Geard CR, Jones JM. Radiation and taxol effects on synchronized human cervical carcinoma cells. Int J Radiat Oncol Biol Phys 1994;29:565-9.
24. Rodriguez M, Sevin BU, Perras J et al. Paclitaxel: a radiation sensitizer of human cervical cancer cells. Gynecol Oncol 1995;57:165-9.
25. Micke O, Bruns F, Schafer U, Prott FJ, Willich N. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy. Anticancer Res 2005;25:1663-6.
26. Choi SH, Kim SH, Choi HJ, Park BK, Lee HJ. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study. J Comput Assist Tomogr 2004;28:620-7.
27. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001;218:776-82.